A human in vitro platform for the evaluation of pharmacology strategies in cardiac ischemia
Cardiac ischemic events increase the risk for arrhythmia, heart attack, heart failure, and death and are the leading mortality condition globally. Reperfusion therapy is the first line of treatment for this condition, and although it significantly reduces mortality, cardiac ischemia remains a signif...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AIP Publishing LLC
2019-09-01
|
| シリーズ: | APL Bioengineering |
| オンライン･アクセス: | http://dx.doi.org/10.1063/1.5089237 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|